Xact Kapitalforvaltning’s Alder Biopharmaceuticals ALDR Stock Holding History

Xact Kapitalforvaltning’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,900	Closed	-$243K	–	1453
2019 Q3	$243K	Hold	12,900	–	–	﹤0.01%	1311
2019 Q2	$152K	Hold	12,900	–	–	﹤0.01%	1413
2019 Q1	$176K	Hold	12,900	–	–	﹤0.01%	1406
2018 Q4	$132K	Hold	12,900	–	–	﹤0.01%	1474
2018 Q3	$215K	Buy	12,900 +2,200	+21%	+$39.8K	﹤0.01%	1505
2018 Q2	$169K	Sell	10,700 -500	-4%	-$7.6K	﹤0.01%	1564
2018 Q1	$142K	Buy	+11,200	New	+$162K	﹤0.01%	1513

Xact Kapitalforvaltning's ALDR Position: Q4 2019 in Review

Xact Kapitalforvaltning sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 12,900 shares — an estimated $243K sold.

Xact Kapitalforvaltning first reported a position in ALDR in Q1 2018 and held it in 7 quarters. The position peaked at $243K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Xact Kapitalforvaltning reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Xact Kapitalforvaltning sold 12,900 Alder Biopharmaceuticals shares in Q4 2019, an estimated $243K.
Xact Kapitalforvaltning first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 7 quarters.
Xact Kapitalforvaltning's Alder Biopharmaceuticals position peaked at $243K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2019, filed 14 Feb 2020.